What if a child’s autism diagnosis could be supported by technology in mere days instead of agonizing months or years, transforming the way families access critical care? Across the globe, families face excruciating delays in obtaining assessments for autism spectrum disorder (ASD), often missing
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, and a deep understanding of technological innovation in the industry. Ivan has been closely involved in groundbreaking studies that are shaping the future of
Imagine a world where treatments for complex diseases are tailored to an individual’s unique genetic makeup, offering hope to patients who have long been out of options, and Alnylam Pharmaceuticals, a pioneer in RNA interference (RNAi) therapeutics, is turning this vision into reality by joining
Imagine a silent health crisis affecting over one-third of adults worldwide, creeping into the lives of millions without noticeable symptoms until it’s too late, and posing a severe threat to both liver and heart health. Metabolic dysfunction-associated steatotic liver disease, commonly known as
What if the secret to managing blood sugar levels tomorrow morning lies in the choices made at tonight’s dinner table? For millions grappling with prediabetes, a condition marked by elevated glucose levels not yet at diabetic thresholds, this question is more than a thought experiment—it’s a
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, combined with a deep understanding of technology and innovation, has positioned him as a leading voice in the industry. Today, we'll dive into the transformative role of
